-
2 New Ebola Vaccines Pass Important Early Test, Researchers Say
Two new Ebola vaccines have passed an important test, protecting monkeys against the strain of the virus responsible for the current deadly outbreak, researchers reported on Wednesday. Only one dose was needed, and there were no apparent side effects.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
South Africa: Tuberculosis – Taxis’ Deadly Passenger
Millions of South Africans rely on minibus taxis daily, but South Africa's most widely used mode of public transport could also be ferrying a deadly passenger.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Saving Lives By Making Malaria Drugs More Affordable
Forty percent of all malaria-caused deaths in sub-Saharan Africa occur in the Democratic Republic of Congo and Nigeria, according to the World Health Organization. The private sector "supply chain" manages 74% of the drug volume in Congo and 98% in Nigeria where malaria-stricken patients rely on "drug shops" and other for-profit retail outlets to get life-saving medicine.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Study: Zambia’s Malaria Success Story Masks Basic Health Failures
A new study reveals that while Zambia has made great progress against malaria over the past decade or so it was losing ground on many other health needs like basic child immunizations and maternal health care.
- Categories
- Health Care
-
Crucial Vaccines Out of Reach for Many in Rural India
The Union health ministry's ambitious Mission Indradhanush to immunise children against various diseases faces a major challenge as the Hib vaccine to safeguard the little ones from deadly infections like meningitis, pneumonia and severe throat conditions remains out of the reach in vast areas of the country.
- Categories
- Health Care
- Region
- South Asia
-
Superslick Coatings Conquer Ketchup, But What About Ebola?
The videos are almost unbelievable. Ketchup slides out of the jar and you don't even have to give it a thump. Glue slips out of the bottle without a molecule left inside. And what about getting that last smidgen of toothpaste from a used tube? No problem.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
GlaxoSmithKline and Merck Ebola Vaccines Succeed in Phase II Liberian Trials
Two Ebola vaccines, one developed by the NIH and GlaxoSmithKline ($GSK) and the other by Merck ($MRK) and NewLink ($NLNK), have sailed through Liberian trials and, based on the results, may now advance to Phase III trials.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Focus on Poverty: Sharing Genetic Data in Health Crises
Genetic information that could help slow disease outbreaks may be kept private by researchers out of fear of violating patients’ rights — that was one of the concerns expressed in a Nature article recently.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.